Commission Implementing Regulation (EU) 2025/1489 of 24 July 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances ametoctradin, Beauveria bassiana strains ATCC 74040 and GHA, buprofezin, clodinafop, copper compounds, cyflumetofen, daminozide, flupyradifurone, Helicoverpa armigera nucleopolyhedrovirus, mandestrobin, mandipropamid, metam, pyraclostrobin, rescalure, Spodoptera littoralis nucleopolyhedrovirus, Streptomyces lydicus strain WYEC 108, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237

Text

Article-level text, parsed from the formex manifestation.

The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

This Regulation shall enter into force on the third day following that of its publication in the Official Journal of the European Union.

What this act cites, and what cites it.

Point-in-time consolidated versions of this act.